High PER1 expression in lung adenocarcinoma patients is associated with STK11-mutation, low hypoxia scores, low tumor and immune cell admixture, high tumor purity, and low tumor-associated PD-L1 expression. Here, STK11 is linked to lung adenocarcinoma.